Newsroom

Newsroom

Entering the Multi-omics and precision medicine era in cancer research

Blog
Read More

NeoGenomics Schedules its Fourth Quarter and Full Year 2021 Earnings Release for February 23, 2022

Press Release
Read More

Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study

Literature
Read More

NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results

Press Release
Read More

The Story, The Patient, The Activist

Blog
Read More

NeoGenomics Announces RaDaR(TM) Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program

Press Release
Read More

Accurate Prediction of Chromosome-Level CNVs from Targeted NGS

Literature
Read More

NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients